Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-01-28 @ 9:51 PM
Study NCT ID:
NCT02934204
Status:
UNKNOWN
Last Update Posted:
2016-10-14
First Post:
2016-10-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma
Sponsor:
Guangdong Provincial People's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GDREC2015431H(R1)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None